Swine Flu Epidemic May Demonstrate Need for Rapid Tests
The 13 billion dollar point-of-care diagnostic industry is ready for the recent deadly outbreak of swine flu, says leading health care market research publisher Kalorama Information.
Read MoreThe 13 billion dollar point-of-care diagnostic industry is ready for the recent deadly outbreak of swine flu, says leading health care market research publisher Kalorama Information.
Read MoreResponse Biomedical Corp announced that it has filed an FDA 510(k) submission seeking clearance to market its Respiratory Syncytial Virus (RSV) test.
Read MoreThe FDA, in response to requests from the US Centers for Disease Control and Prevention, has issued Emergency Use Authorizations (EUAs) to make available to public health and medical personnel important diagnostic and therapeutic tools to identify and respond to the swine flu virus under certain circumstances.
Read MoreCopan Diagnostics range of flocked swabs have been shown in independent clinical studies to improve the results of respiratory virus diagnostic tests by collecting more patient specimen and then delivering the entire sample into the assay platform or cell culture tube.
Read MoreProdesse Inc announces the results of in silico testing of its ProFlu+ Assay that demonstrate the Assay detects the currently circulating swine flu virus.
Read More